DOI: 10.1182/blood.v98.12.3340. Blockade of adenosine diphosphate receptors P2Y12 and P2Y1 is required to inhibit platelet aggregation in whole blood under flow

Blockade of adenosine diphosphate receptors P2Y12 and P2Y1 is required to inhibit platelet aggregation in whole blood under flow

10.1182/blood.v98.12.3340

Crossref journal-article

American Society of Hematology

Blood (234)

Abstract

Abstract Using heparinized whole blood and flow conditions, it was shown that adenosine 5′-diphosphate (ADP) receptors P2Y12 and P2Y1 are both important in direct shear-induced platelet aggregation and platelet aggregation subsequent to initial adhesion onto von Willebrand factor (vWf)–collagen. In the viscometer, whole blood was subjected to shear rates of 750, 1500, and 3000 s−1 for 30 seconds at room temperature. The extent of aggregation was determined by flow cytometry. The P2Y12antagonist AR-C69 931MX (ARMX) reduced shear-induced aggregation at these rates by 56%, 54%, and 16%, respectively, compared to control samples. Adenosine 3′,5′-diphosphate (A3P5P; P2Y1antagonist) inhibited shear-induced aggregation by 40%, 30% and 29%, respectively, compared to control samples. Blockade of both ADP receptors at 3000 s−1 with ARMX plus A3P5P further reduced the platelet aggregation by 41% compared to the addition of ARMX alone (57% compared to control samples). Using a parallel-plate flow chamber, whole blood was perfused over bovine collagen type 1 at a wall shear rate of 3000 s−1 for 60 seconds. Platelet deposition was quantified with epifluorescence video microscopy and digital image processing. Blockade of P2Y12 alone or blockade of P2Y1 alone did not reduce thrombus formation on vWf–collagen. In contrast, blockade of both P2Y12 and P2Y1 reduced platelet deposition by 72%. These results indicate that combinations of antagonists of the ADP receptors P2Y12 and P2Y1 are effective inhibitors of direct shear-induced platelet aggregation and of platelet aggregation subsequent to initial adhesion under flow conditions. Inhibitors of these pathways are potentially useful as antiarterial thrombotic agents.

Bibliography

Turner, N. A., Moake, J. L., & McIntire, L. V. (2001). Blockade of adenosine diphosphate receptors P2Y12 and P2Y1 is required to inhibit platelet aggregation in whole blood under flow. Blood, 98(12), 3340â3345.

Authors 3

Nancy A. Turner (first)
Joel L. Moake (additional)
Larry V. McIntire (additional)

References 33 Referenced 123

10.1172/JCI115124 / J Clin Invest. / The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. by Ikeda (1991)
10.1172/JCI112736 / J Clin Invest. / Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. by Moake (1986)
10.1182/blood.V69.2.625.625 / Blood. / Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. by Peterson (1987)
10.1182/blood.V71.5.1366.1366 / Blood. / Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin. by Moake (1988)
10.1055/s-0038-1650674 / Thromb Haemost. / ADP receptors on platelets. by Mills (1996)
10.1182/blood.V92.1.152.413k27_152_159 / Blood. / The P2Y1 receptor is necessary for adenosine 5′-diphosphate-induced platelet aggregation. by Hechler (1998)
10.1055/s-0037-1614427 / Thromb Haemost. / Evidence for two distinct G-protein–coupled ADP receptors mediating platelet activation. by Jantzen (1999)
10.1172/JCI8399 / J Clin Invest. / Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor-null mice. by Leon (1999)
10.1055/s-0037-1614570 / Thromb Haemost. / The P2Y1 receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation. by Leon (1999)
10.1111/j.1476-5381.1995.tb15925.x / Br J Pharmacol. / Pharmacological profile of the novel P2T-purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo. by Humphries (1995)
10.1016/S0165-6147(00)89018-5 / Trends Pharmacol Sci. / A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis. by Humphries (1995)
{'key': '2020021223060678300_B12', 'first-page': '203', 'article-title': 'The role of ADP in thrombosis and the therapeutic potential of P2T-receptor antagonists as novel antithrombotic agents.', 'volume-title': 'Purinergic Approaches in Experimental Therapeutics.', 'author': 'Leff', 'year': '1997'} / Purinergic Approaches in Experimental Therapeutics. / The role of ADP in thrombosis and the therapeutic potential of P2T-receptor antagonists as novel antithrombotic agents. by Leff (1997)
10.1161/01.ATV.19.10.2281 / Arterioscler Thromb Vasc Biol. / ADP receptors and clinical bleeding disorders. by Cattaneo (1999)
10.1016/S0898-6568(00)00083-8 / Cell Signal. / Advances in signalling by extracellular nucleotides: the role and transduction mechanisms of P2Y receptors. by Communi (2000)
10.1055/s-0037-1614049 / Thromb Haemost. / Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors. by Baurand (2000)
10.1038/35051599 / Nature. / Identification of the platelet ADP receptor targeted by antithrombotic drugs. by Hollopeter (2001)
10.1161/01.CIR.100.15.1667 / Circulation. / Ticlopidine and clopidogrel. by Quinn (1999)
10.1073/pnas.95.14.8070 / Proc Natl Acad Sci U S A. / Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. by Jin (1998)
10.1182/blood.V81.5.1263.1263 / Blood. / Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. by Alevriadou (1993)
10.1115/1.2894104 / J Biomech Eng. / Wall shear stress estimates in coronary artery constrictions. by Back (1992)
{'key': '2020021223060678300_B21', 'first-page': '139', 'article-title': 'Blood viscosity, mass transport, and thrombogenesis [abstract].', 'volume': '6', 'author': 'Turritto', 'year': '1982', 'journal-title': 'Prog Hemost Thromb.'} / Prog Hemost Thromb. / Blood viscosity, mass transport, and thrombogenesis [abstract]. by Turritto (1982)
10.1021/jm981072s / J Med Chem. / Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy. by Ingall (1999)
10.1161/01.CIR.91.5.1354 / Circulation. / Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa. by Turner (1995)
10.1161/01.CIR.101.10.1122 / Circulation. / Effects of abciximab, ticlopidine, and combined abciximab/ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty. by Fredrickson (2000)
10.1016/S0006-2952(00)00279-3 / Biochem Pharmacol. / On the mechanism of plasmin-induced platelet aggregation. by Ishii-Watabe (2000)
10.1172/JCI110973 / J Clin Invest. / A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. by Coller (1983)
10.3233/BIR-1995-32106 / Biorheology. / Flow cytometric studies of platelet responses to shear stress in whole blood. by Konstantopoulos (1995)
10.1063/1.1138830 / Rev Sci Instrum. / Technique for visualization and analysis of mural thrombogenesis. by Hubbell (1986)
10.1074/jbc.273.4.2030 / J Biol Chem. / Molecular basis for ADP-induced platelet activation. by Jin (1998)
10.1046/j.1365-2141.2000.02208.x / Br J Haematol. / The central role of the P2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity. by Storey (2000)
10.1182/blood.V75.5.1081.1081 / Blood. / Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates. by Cattaneo (1990)
10.1111/j.1365-2141.1986.tb07552.x / Br J Haematol. / The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium. by Sakariassen (1986)
{'key': '2020021223060678300_B33', 'first-page': '87', 'article-title': 'Ectonucleotidases: measurement of activities and use of inhibitors.', 'volume': '6', 'author': 'Pearson', 'year': '1985', 'journal-title': 'Methods Pharmacol.'} / Methods Pharmacol. / Ectonucleotidases: measurement of activities and use of inhibitors. by Pearson (1985)

Dates

Type	When
Created	23 years, 1 month ago (July 27, 2002, 4:46 a.m.)
Deposited	5 years, 6 months ago (Feb. 12, 2020, 6:07 p.m.)
Indexed	4 months, 1 week ago (April 17, 2025, 4:26 a.m.)
Issued	23 years, 8 months ago (Dec. 1, 2001)
Published	23 years, 8 months ago (Dec. 1, 2001)
Published Print	23 years, 8 months ago (Dec. 1, 2001)

Funders 0

None

BibTeX

@article{Turner_2001, title={Blockade of adenosine diphosphate receptors P2Y12 and P2Y1 is required to inhibit platelet aggregation in whole blood under flow}, volume={98}, ISSN={0006-4971}, url={http://dx.doi.org/10.1182/blood.v98.12.3340}, DOI={10.1182/blood.v98.12.3340}, number={12}, journal={Blood}, publisher={American Society of Hematology}, author={Turner, Nancy A. and Moake, Joel L. and McIntire, Larry V.}, year={2001}, month=dec, pages={3340–3345} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        4,
        17
      ]
    ],
    "date-time": "2025-04-17T08:26:21Z",
    "timestamp": 1744878381495
  },
  "reference-count": 33,
  "publisher": "American Society of Hematology",
  "issue": "12",
  "content-domain": {
    "domain": [
      "ashpublications.org"
    ],
    "crossmark-restriction": true
  },
  "published-print": {
    "date-parts": [
      [
        2001,
        12,
        1
      ]
    ]
  },
  "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>Using heparinized whole blood and flow conditions, it was shown that adenosine 5\u2032-diphosphate (ADP) receptors P2Y12 and P2Y1 are both important in direct shear-induced platelet aggregation and platelet aggregation subsequent to initial adhesion onto von Willebrand factor (vWf)\u2013collagen. In the viscometer, whole blood was subjected to shear rates of 750, 1500, and 3000 s\u22121 for 30 seconds at room temperature. The extent of aggregation was determined by flow cytometry. The P2Y12antagonist AR-C69\u2009931MX (ARMX) reduced shear-induced aggregation at these rates by 56%, 54%, and 16%, respectively, compared to control samples. Adenosine 3\u2032,5\u2032-diphosphate (A3P5P; P2Y1antagonist) inhibited shear-induced aggregation by 40%, 30% and 29%, respectively, compared to control samples. Blockade of both ADP receptors at 3000 s\u22121 with ARMX plus A3P5P further reduced the platelet aggregation by 41% compared to the addition of ARMX alone (57% compared to control samples). Using a parallel-plate flow chamber, whole blood was perfused over bovine collagen type 1 at a wall shear rate of 3000 s\u22121 for 60 seconds. Platelet deposition was quantified with epifluorescence video microscopy and digital image processing. Blockade of P2Y12 alone or blockade of P2Y1 alone did not reduce thrombus formation on vWf\u2013collagen. In contrast, blockade of both P2Y12 and P2Y1 reduced platelet deposition by 72%. These results indicate that combinations of antagonists of the ADP receptors P2Y12 and P2Y1 are effective inhibitors of direct shear-induced platelet aggregation and of platelet aggregation subsequent to initial adhesion under flow conditions. Inhibitors of these pathways are potentially useful as antiarterial thrombotic agents.</jats:p>",
  "DOI": "10.1182/blood.v98.12.3340",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2002,
        7,
        27
      ]
    ],
    "date-time": "2002-07-27T08:46:40Z",
    "timestamp": 1027759600000
  },
  "page": "3340-3345",
  "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000",
  "source": "Crossref",
  "is-referenced-by-count": 123,
  "title": "Blockade of adenosine diphosphate receptors P2Y12 and P2Y1 is required to inhibit platelet aggregation in whole blood under flow",
  "prefix": "10.1182",
  "volume": "98",
  "author": [
    {
      "given": "Nancy A.",
      "family": "Turner",
      "sequence": "first",
      "affiliation": [
        {
          "name": "From the Department of Bioengineering, Rice University, and the Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX."
        }
      ]
    },
    {
      "given": "Joel L.",
      "family": "Moake",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Department of Bioengineering, Rice University, and the Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX."
        }
      ]
    },
    {
      "given": "Larry V.",
      "family": "McIntire",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Department of Bioengineering, Rice University, and the Division of Hematology/Oncology, Baylor College of Medicine, Houston, TX."
        }
      ]
    }
  ],
  "member": "234",
  "reference": [
    {
      "key": "2020021223060678300_B1",
      "doi-asserted-by": "crossref",
      "first-page": "1234",
      "DOI": "10.1172/JCI115124",
      "article-title": "The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress.",
      "volume": "87",
      "author": "Ikeda",
      "year": "1991",
      "journal-title": "J Clin Invest."
    },
    {
      "key": "2020021223060678300_B2",
      "doi-asserted-by": "crossref",
      "first-page": "1456",
      "DOI": "10.1172/JCI112736",
      "article-title": "Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.",
      "volume": "78",
      "author": "Moake",
      "year": "1986",
      "journal-title": "J Clin Invest."
    },
    {
      "key": "2020021223060678300_B3",
      "doi-asserted-by": "crossref",
      "first-page": "625",
      "DOI": "10.1182/blood.V69.2.625.625",
      "article-title": "Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa.",
      "volume": "69",
      "author": "Peterson",
      "year": "1987",
      "journal-title": "Blood."
    },
    {
      "key": "2020021223060678300_B4",
      "doi-asserted-by": "crossref",
      "first-page": "1366",
      "DOI": "10.1182/blood.V71.5.1366.1366",
      "article-title": "Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large vWF multimers, requires adenosine diphosphate, and is resistant to aspirin.",
      "volume": "71",
      "author": "Moake",
      "year": "1988",
      "journal-title": "Blood."
    },
    {
      "key": "2020021223060678300_B5",
      "doi-asserted-by": "crossref",
      "first-page": "835",
      "DOI": "10.1055/s-0038-1650674",
      "article-title": "ADP receptors on platelets.",
      "volume": "76",
      "author": "Mills",
      "year": "1996",
      "journal-title": "Thromb Haemost."
    },
    {
      "key": "2020021223060678300_B6",
      "doi-asserted-by": "crossref",
      "first-page": "152",
      "DOI": "10.1182/blood.V92.1.152.413k27_152_159",
      "article-title": "The P2Y1 receptor is necessary for adenosine 5\u2032-diphosphate-induced platelet aggregation.",
      "volume": "92",
      "author": "Hechler",
      "year": "1998",
      "journal-title": "Blood."
    },
    {
      "key": "2020021223060678300_B7",
      "doi-asserted-by": "crossref",
      "first-page": "111",
      "DOI": "10.1055/s-0037-1614427",
      "article-title": "Evidence for two distinct G-protein\u2013coupled ADP receptors mediating platelet activation.",
      "volume": "81",
      "author": "Jantzen",
      "year": "1999",
      "journal-title": "Thromb Haemost."
    },
    {
      "key": "2020021223060678300_B8",
      "doi-asserted-by": "crossref",
      "first-page": "1731",
      "DOI": "10.1172/JCI8399",
      "article-title": "Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor-null mice.",
      "volume": "104",
      "author": "Leon",
      "year": "1999",
      "journal-title": "J Clin Invest."
    },
    {
      "key": "2020021223060678300_B9",
      "doi-asserted-by": "crossref",
      "first-page": "775",
      "DOI": "10.1055/s-0037-1614570",
      "article-title": "The P2Y1 receptor is normal in a patient presenting a severe deficiency of ADP-induced platelet aggregation.",
      "volume": "81",
      "author": "Leon",
      "year": "1999",
      "journal-title": "Thromb Haemost."
    },
    {
      "key": "2020021223060678300_B10",
      "doi-asserted-by": "crossref",
      "first-page": "1110",
      "DOI": "10.1111/j.1476-5381.1995.tb15925.x",
      "article-title": "Pharmacological profile of the novel P2T-purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo.",
      "volume": "115",
      "author": "Humphries",
      "year": "1995",
      "journal-title": "Br J Pharmacol."
    },
    {
      "key": "2020021223060678300_B11",
      "doi-asserted-by": "crossref",
      "first-page": "179",
      "DOI": "10.1016/S0165-6147(00)89018-5",
      "article-title": "A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosis.",
      "volume": "16",
      "author": "Humphries",
      "year": "1995",
      "journal-title": "Trends Pharmacol Sci."
    },
    {
      "key": "2020021223060678300_B12",
      "first-page": "203",
      "article-title": "The role of ADP in thrombosis and the therapeutic potential of P2T-receptor antagonists as novel antithrombotic agents.",
      "volume-title": "Purinergic Approaches in Experimental Therapeutics.",
      "author": "Leff",
      "year": "1997"
    },
    {
      "key": "2020021223060678300_B13",
      "doi-asserted-by": "crossref",
      "first-page": "2281",
      "DOI": "10.1161/01.ATV.19.10.2281",
      "article-title": "ADP receptors and clinical bleeding disorders.",
      "volume": "19",
      "author": "Cattaneo",
      "year": "1999",
      "journal-title": "Arterioscler Thromb Vasc Biol."
    },
    {
      "key": "2020021223060678300_B14",
      "doi-asserted-by": "crossref",
      "first-page": "351",
      "DOI": "10.1016/S0898-6568(00)00083-8",
      "article-title": "Advances in signalling by extracellular nucleotides: the role and transduction mechanisms of P2Y receptors.",
      "volume": "12",
      "author": "Communi",
      "year": "2000",
      "journal-title": "Cell Signal."
    },
    {
      "key": "2020021223060678300_B15",
      "doi-asserted-by": "crossref",
      "first-page": "484",
      "DOI": "10.1055/s-0037-1614049",
      "article-title": "Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.",
      "volume": "84",
      "author": "Baurand",
      "year": "2000",
      "journal-title": "Thromb Haemost."
    },
    {
      "key": "2020021223060678300_B16",
      "doi-asserted-by": "crossref",
      "first-page": "202",
      "DOI": "10.1038/35051599",
      "article-title": "Identification of the platelet ADP receptor targeted by antithrombotic drugs.",
      "volume": "409",
      "author": "Hollopeter",
      "year": "2001",
      "journal-title": "Nature."
    },
    {
      "key": "2020021223060678300_B17",
      "doi-asserted-by": "crossref",
      "first-page": "1667",
      "DOI": "10.1161/01.CIR.100.15.1667",
      "article-title": "Ticlopidine and clopidogrel.",
      "volume": "100",
      "author": "Quinn",
      "year": "1999",
      "journal-title": "Circulation."
    },
    {
      "key": "2020021223060678300_B18",
      "doi-asserted-by": "crossref",
      "first-page": "8070",
      "DOI": "10.1073/pnas.95.14.8070",
      "article-title": "Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation.",
      "volume": "95",
      "author": "Jin",
      "year": "1998",
      "journal-title": "Proc Natl Acad Sci U S A."
    },
    {
      "key": "2020021223060678300_B19",
      "doi-asserted-by": "crossref",
      "first-page": "1263",
      "DOI": "10.1182/blood.V81.5.1263.1263",
      "article-title": "Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets.",
      "volume": "81",
      "author": "Alevriadou",
      "year": "1993",
      "journal-title": "Blood."
    },
    {
      "key": "2020021223060678300_B20",
      "doi-asserted-by": "crossref",
      "first-page": "515",
      "DOI": "10.1115/1.2894104",
      "article-title": "Wall shear stress estimates in coronary artery constrictions.",
      "volume": "114",
      "author": "Back",
      "year": "1992",
      "journal-title": "J Biomech Eng."
    },
    {
      "key": "2020021223060678300_B21",
      "first-page": "139",
      "article-title": "Blood viscosity, mass transport, and thrombogenesis [abstract].",
      "volume": "6",
      "author": "Turritto",
      "year": "1982",
      "journal-title": "Prog Hemost Thromb."
    },
    {
      "key": "2020021223060678300_B22",
      "doi-asserted-by": "crossref",
      "first-page": "213",
      "DOI": "10.1021/jm981072s",
      "article-title": "Antagonists of the platelet P2T receptor: a novel approach to antithrombotic therapy.",
      "volume": "42",
      "author": "Ingall",
      "year": "1999",
      "journal-title": "J Med Chem."
    },
    {
      "key": "2020021223060678300_B23",
      "doi-asserted-by": "crossref",
      "first-page": "1354",
      "DOI": "10.1161/01.CIR.91.5.1354",
      "article-title": "Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa.",
      "volume": "91",
      "author": "Turner",
      "year": "1995",
      "journal-title": "Circulation."
    },
    {
      "key": "2020021223060678300_B24",
      "doi-asserted-by": "crossref",
      "first-page": "1122",
      "DOI": "10.1161/01.CIR.101.10.1122",
      "article-title": "Effects of abciximab, ticlopidine, and combined abciximab/ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty.",
      "volume": "101",
      "author": "Fredrickson",
      "year": "2000",
      "journal-title": "Circulation."
    },
    {
      "key": "2020021223060678300_B25",
      "doi-asserted-by": "crossref",
      "first-page": "1345",
      "DOI": "10.1016/S0006-2952(00)00279-3",
      "article-title": "On the mechanism of plasmin-induced platelet aggregation.",
      "volume": "59",
      "author": "Ishii-Watabe",
      "year": "2000",
      "journal-title": "Biochem Pharmacol."
    },
    {
      "key": "2020021223060678300_B26",
      "doi-asserted-by": "crossref",
      "first-page": "325",
      "DOI": "10.1172/JCI110973",
      "article-title": "A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.",
      "volume": "72",
      "author": "Coller",
      "year": "1983",
      "journal-title": "J Clin Invest."
    },
    {
      "key": "2020021223060678300_B27",
      "doi-asserted-by": "crossref",
      "first-page": "73",
      "DOI": "10.3233/BIR-1995-32106",
      "article-title": "Flow cytometric studies of platelet responses to shear stress in whole blood.",
      "volume": "32",
      "author": "Konstantopoulos",
      "year": "1995",
      "journal-title": "Biorheology."
    },
    {
      "key": "2020021223060678300_B28",
      "doi-asserted-by": "crossref",
      "first-page": "892",
      "DOI": "10.1063/1.1138830",
      "article-title": "Technique for visualization and analysis of mural thrombogenesis.",
      "volume": "57",
      "author": "Hubbell",
      "year": "1986",
      "journal-title": "Rev Sci Instrum."
    },
    {
      "key": "2020021223060678300_B29",
      "doi-asserted-by": "crossref",
      "first-page": "2030",
      "DOI": "10.1074/jbc.273.4.2030",
      "article-title": "Molecular basis for ADP-induced platelet activation.",
      "volume": "273",
      "author": "Jin",
      "year": "1998",
      "journal-title": "J Biol Chem."
    },
    {
      "key": "2020021223060678300_B30",
      "doi-asserted-by": "crossref",
      "first-page": "925",
      "DOI": "10.1046/j.1365-2141.2000.02208.x",
      "article-title": "The central role of the P2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.",
      "volume": "110",
      "author": "Storey",
      "year": "2000",
      "journal-title": "Br J Haematol."
    },
    {
      "key": "2020021223060678300_B31",
      "doi-asserted-by": "crossref",
      "first-page": "1081",
      "DOI": "10.1182/blood.V75.5.1081.1081",
      "article-title": "Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates.",
      "volume": "75",
      "author": "Cattaneo",
      "year": "1990",
      "journal-title": "Blood."
    },
    {
      "key": "2020021223060678300_B32",
      "doi-asserted-by": "crossref",
      "first-page": "681",
      "DOI": "10.1111/j.1365-2141.1986.tb07552.x",
      "article-title": "The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium.",
      "volume": "63",
      "author": "Sakariassen",
      "year": "1986",
      "journal-title": "Br J Haematol."
    },
    {
      "key": "2020021223060678300_B33",
      "first-page": "87",
      "article-title": "Ectonucleotidases: measurement of activities and use of inhibitors.",
      "volume": "6",
      "author": "Pearson",
      "year": "1985",
      "journal-title": "Methods Pharmacol."
    }
  ],
  "container-title": "Blood",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "http://ashpublications.org/blood/article-pdf/98/12/3340/1678912/h8230103340.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "syndication"
    },
    {
      "URL": "http://ashpublications.org/blood/article-pdf/98/12/3340/1678912/h8230103340.pdf",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2020,
        2,
        12
      ]
    ],
    "date-time": "2020-02-12T23:07:04Z",
    "timestamp": 1581548824000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://ashpublications.org/blood/article/98/12/3340/53222/Blockade-of-adenosine-diphosphate-receptors-P2Y12"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2001,
        12,
        1
      ]
    ]
  },
  "references-count": 33,
  "journal-issue": {
    "issue": "12",
    "published-print": {
      "date-parts": [
        [
          2001,
          12,
          1
        ]
      ]
    }
  },
  "URL": "http://dx.doi.org/10.1182/blood.V98.12.3340",
  "relation": {},
  "ISSN": [
    "1528-0020",
    "0006-4971"
  ],
  "subject": [],
  "published": {
    "date-parts": [
      [
        2001,
        12,
        1
      ]
    ]
  }
}